CNBC - Health
Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity
12 hours ago
Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform12 hours ago
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month1 day ago
Congress hemp ban raises fears of mass layoffs and black market growth1 day ago
U.S. employer health plans tap prescriptions that feds say are illegal5 days ago
Healthy Returns: Novo Nordisk boosts the case for its obesity pill with new data5 days ago
Rocket Lab posts record third-quarter revenue, launch backlog7 days ago
Trump tells Republicans to send health insurance money 'directly to the people'7 days ago
Trump's deals with Eli Lilly, Novo Nordisk could broaden obesity drug access10 days ago
Startup Omada Health to start prescribing GLP-1s, other obesity medications11 days ago
Here's how much weight loss drugs could cost under Trump's deals with Lilly, Novo12 days ago
Trump announces deal with Eli Lilly, Novo Nordisk to cut weight loss drug prices12 days ago
Eli Lilly to start late-stage trials on amylin obesity drug after promising data12 days ago
Healthy Returns: Pfizer, Novo Nordisk escalate bidding war over Metsera12 days ago
Metsera says Novo Nordisk's new bid is 'superior' to revised Pfizer offer13 days ago
Pfizer tops estimates, raises profit guidance even as sales fall14 days ago
Pfizer files second lawsuit against Novo Nordisk, Metsera in obesity bidding war14 days ago
Where the blockbuster weight loss drug market stands today — and what's coming next16 days ago
'Trump effect' raises hopes for cannabis rally as investors bet on change16 days ago
Breast cancer drug stock Olema Pharmaceutical could more than double from here17 days ago
This biotech stock has jumped 50% in 3 months19 days ago
We're raising our Eli Lilly price target — what a difference a quarter makes19 days ago
Midi Health introducing testosterone therapy as demand from women spikes19 days ago
Eli Lilly blows past estimates, hikes guidance on Zepbound and Mounjaro sales19 days ago
Merck tops estimates on Keytruda strength and narrows profit outlook19 days ago
FDA to speed up approvals of biosimilars as Trump targets high drug costs19 days ago
Eli Lilly, Walmart to offer discounted retail option for obesity drug Zepbound20 days ago
CVS beats estimates, hikes guidance as insurance business improves20 days ago
Eli Lilly, Nvidia to build supercomputer, AI factory for drug discovery20 days ago
Healthy Returns: What to expect from Eli Lilly, Merck, AbbVie Q3 earnings21 days ago
Novartis CEO says firm has the firepower for big M&A deals: 'Can never be done'21 days ago
Healthy Returns: A key step forward for Novo Nordisk's GLP-1 pill28 days ago
Why cattlemen say Trump Argentine beef import idea no solution for record prices28 days ago
Novo Nordisk chair and directors quit after boardroom rift28 days ago
